Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG - Hadji, Peyman (Krankenhaus Nordwest) ; Aapro, Matti S. (Genolier Cancer Center, Switzerland) ; Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ; Gnant, Michael (Medical University of Vienna, Austria) ; Brandi, Maria Luisa (University of Florence, Italy) ; Reginster, Jean Yves (University of Liège, Belgium) ; Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ; Glüer, Claus-C. (Univeristy of Kiel, Germany) ; de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ; Baber, Rod (University of Sydney, Australia) ; Roodman, G. David (Indiana University School of Medicine, USA) ; Cooper, Cyrus (University of Southampton, UK) ; Langdahl, Bente (Aarhus University, Denmark) ; Palacios, Santiago (Instituto Palacios Madrid, Spain) ; Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ; Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ; Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ; Eriksen, Erik Fink (University of Oslo, Norway) ; Kurth, Andreas (Klinikum Birkenwerder, Germany) ; Rizzoli, Rene (Geneva University, Switzerland) ; Coleman, Robert E. (University of Sheffield, UK)
 
Comentaris (0) | Ressenyes (0)
Enceteu un debat sobre qualsevol aspecte d'aquest document.

 Subscriure's to this discussion. You will then receive all new comments by email.

Afegeix un comentari


Un cop identificats, els usuaris autoritzats també hi poden adjuntar fitxers.
Vigileu: encara no heu definit el vostre àlies.
N/D s'usarà temporalment com a autor d'aquest comentari.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>